This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.93% per year. These returns cover a period from January 1, 1988 through October 6, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Globe Life Q3 Earnings Beat Estimates on Solid Underwriting
by Zacks Equity Research
GL's third-quarter results reflect higher Life and Health insurance premiums, improved insurance underwriting income, and lower expenses.
Compared to Estimates, Globe Life (GL) Q3 Earnings: A Look at Key Metrics
by Zacks Equity Research
While the top- and bottom-line numbers for Globe Life (GL) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Globe Life (GL) Surpasses Q3 Earnings Estimates
by Zacks Equity Research
Globe Life (GL) delivered earnings and revenue surprises of +5.95% and -0.12%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Globe Life (GL) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates
by Zacks Equity Research
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Globe Life (GL), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2025.
Globe Life (GL) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Globe Life (GL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Trupanion Grows in Pet Insurance Amid Rising Veterinary Care Costs
by Zacks Equity Research
Trupanion rides on strong retention, new products and global expansion to boost revenues and outpace its industry peers.
Unum Group to Benefit From Growing Premium Amid Cost Woes
by Zacks Equity Research
UNM stock gains from improved premium income, higher sales, strong persistency, and effective capital deployment.
Rising Sales & Declining Cash Flows: The Aflac Investor Dilemma
by Zacks Equity Research
AFL's sales surge in Japan and the United States, but declining cash flows raise questions over its growth flexibility.
Here's Why Globe Life (GL) is a Strong Momentum Stock
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Globe Life Is Trading at a Discount: Time to Load Up or Hold Off?
by Zacks Equity Research
GL builds on niche markets and agency expansion to boost premiums but rising expenses and higher debt weigh on margins.
Zacks Industry Outlook Highlights Aflac, Trupanion and Globe Life
by Zacks Equity Research
Zacks highlights Aflac, Trupanion, and Globe Life as key stocks in the accident & health insurance industry, which faces pricing pressure but benefits from tech adoption, underwriting strength, and growing demand.
3 Accident & Health Insurance Stocks to Watch Amid Pricing Pressure
by Tanuka De
Accident and Health Insurance stocks like AFL, TRUP and GL are set to gain from rising underwriting exposure and accelerated digitalization. However, pricing pressure is a concern given rising medical costs and inflation.
Why Is Globe Life (GL) Up 6.2% Since Last Earnings Report?
by Zacks Equity Research
Globe Life (GL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
GL Outperforms Industry, Trades Above 50-Day SMA: What's Next?
by Zacks Equity Research
Globe Life is set to grow on well-performing American Income and Liberty National divisions, higher invested assets and a strong liquidity position.
Unum to Benefit From Growing Premium Amid Rising Expenses
by Zacks Equity Research
Unum Group sees Q2 premium gains, but rising costs, margin pressure, and weak ROE temper its performance.
Here's Why Globe Life (GL) is a Strong Momentum Stock
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Globe Life (GL) is a Top Momentum Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Globe Life Q2 Earnings & Revenues Top Estimates on Strong Underwriting
by Zacks Equity Research
GL's Q2 earnings increase 10% as strong Life and Health premiums offset declines in investment income and rising expenses.
Globe Life (GL) Beats Q2 Earnings Estimates
by Zacks Equity Research
Globe Life (GL) delivered earnings and revenue surprises of +0.62% and -0.42%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Is the Options Market Predicting a Spike in Globe Life Stock?
by Zacks Equity Research
Investors need to pay close attention to GL stock based on the movements in the options market lately.
Exploring Analyst Estimates for Globe Life (GL) Q2 Earnings, Beyond Revenue and EPS
by Zacks Equity Research
Get a deeper insight into the potential performance of Globe Life (GL) for the quarter ended June 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
Globe Life (GL) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Globe Life (GL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
GL Stock Trading at a Discount to Industry at 8.22X: Time to Hold?
by Zacks Equity Research
Globe Life is set to grow on well-performing American Income and Liberty National divisions, higher invested assets and a strong liquidity position.
Zacks Industry Outlook Highlights Aflac, Unum, Trupanion, Globe Life and AMERISAFE
by Zacks Equity Research
AFL, UNM, TRUP, GL and AMSF are poised to gain from rising exposure and tech adoption despite pricing pressure.
5 Accident & Health Insurance Stocks to Watch as Exposure Increases
by Tanuka De
Accident & Health Insurers AFL, UNM, TRUP, GL and AMSF are set to gain from rising underwriting exposure, despite ongoing pricing pressure.